GENETWORx Launches a New Personal Health Panel for Advanced

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
GENETWORx Launches a New Personal Health Panel for Advanced Diagnosis of Genital and Gastrointestinal Pathogens

HENRICO COUNTY, Va., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Richmond, Virginia-area laboratory GENETWORx has launched a new test panel that provides actionable-patient centered diagnostics to help physicians determine the most appropriate treatment regimen for patients suffering from genital and/or gastrointestinal infections.

The Personal Health Panel utilizes advanced multiplex DNA sequencing to detect a wide variety of pathogens including those shown to be resistant to common drug therapies. Identifying drug resistant pathogens allows for more targeted drug therapy with the goal of a reduction in treatment failures and optimal patient health outcomes.

Many infectious diseases, such as common sexually transmitted diseases and viruses that infect the gastrointestinal tract can have similar symptoms and treatments. The GENETWORx Personal Health Panel test results combined with advanced pharmacodiagnostic reporting helps providers not only identify the specific strain of the infection; it also identifies medication therapy options to aid in successful treatment of each patient based on their individual results. This helps prescribers move away from broad-spectrum drug therapy to a precision based approach to prescribing.

GENETWORx CEO William Miller says, "The new Personal Health Panel further demonstrates our commitment to personalized medicine and revolutionizing the diagnostic laboratory industry. We pride ourselves in being a – Service Provider- and not just another laboratory who performs testing. The new panel also meshes well with our current pharmacogenetics panel, and together these results can be integrated into the overall treatment consideration to allow for more efficient therapeutic regimens, which will lead to more effective results for the patient."

The Personal Health Panel will be marketed to gastroenterologists, gynecologists and Primary Care physicians. It will offer the widest array of molecular diagnostic assays available on the market, with easy sample collection and one of the shortest turnaround times available. Results will be reported within 24-48 hours after the sample is received at the laboratory and delivered to the physician via Provider preference (e.g. hard copy, secure web portal, or desktop delivery).

About GENETWORx

GENETWORx is a fully accredited laboratory based in Glen Allen, Virginia. Its mission is to deliver meaningful personalized medicine results to patients and provide health care professionals the necessary tools to leverage their knowledge and truly individualize treatment plans based on a patient's DNA. Its scientists utilize the latest technology in DNA sequencing to help physicians choose the right medications, at the right dose, and effectively lower overall healthcare expenditures while delivering the best health outcome for the patient. For more information, visit the GENETWORx website at www.genetworx.com .

For more information contact: William Miller, CEO, MBA, HTL GENETWORx 4060 Innslake Drive Glen Allen, VA 23060

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Google Search Data Sharing Faces a Privacy Reality Check

Updated Category News Views 33

Search queries are messy little confessions, and that is exactly why this case deserves more than a bureaucratic shrug. Woodway Assurance's independent assessment says Google's search-query data could be treated as anonymized for sharing under the Digital Markets Act, but only if the European Commission tightens parts of its July 2026 framework. That is not a clean bill...

Continue Reading
Voranigo Follow-Up Deepens the Glioma Care Debate Today

Updated Category News Views 136

Brain-tumor progress rarely arrives with a clean victory lap, but the longer INDIGO readout gives clinicians and sector watchers something sturdier than a one-time headline. Servier presented extended Phase 3 results for VORANIGO, or vorasidenib, at the Society for Neuro-Oncology meeting in Philadelphia on November 14 and 15, 2026. The central message is durable benefit...

Continue Reading
PSEG Declares $0.67 Fourth-Quarter 2026 Cash Dividend

Updated Category News Views 112

A 67-cent utility dividend rarely sets the tape on fire, and that is precisely the point. Public Service Enterprise Group declared a regular fourth-quarter 2026 common-stock dividend of $0.67 per share, payable on or before December 31 to shareholders of record on December 10. For owners of NYSE:PEG, this is the sort of announcement that belongs in the “steady as she...

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 196

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
SecureSpace Plants a Fifth Flag in Miami Beach Storage

Updated Category News Views 111

A small box on Alton Road may carry outsized weight Miami Beach does not hand out cheap, easy real estate wins, which is why SecureSpace's opening at 633 Alton Road deserves a closer look than its modest footprint might suggest. The newly rebranded SecureSpace Miami Beach facility has 18,358 square feet of traditional storage and locker space spread across 536 units, plus...

Continue Reading
Dolby's Strong Quarter Meets a Flat 2027 Reality Check

Updated Category News Views 67

A licensing machine just coughed up a very good quarter, then told investors not to expect the engine to accelerate next year. That is the whole Dolby story in one uncomfortable breath. NYSE:DLB finished fiscal 2026 with fourth-quarter revenue of $374 million, up from $307 million a year earlier, while GAAP diluted earnings climbed to $0.86 from $0.51. Those are not...

Continue Reading
USFM's Disko Deal Waits on Greenland Until March 2027

Updated Category News Views 184

A missing Greenland signature has turned USFM’s grand Disko plan into a calendar problem. Nothing more dramatic has been disclosed, but nothing less consequential should be assumed either. March 31 replaces a deadline that already failed USFM executed its share purchase agreement with 80 Mile PLC and Disko Exploration Limited on May 8, 2026. The proposed bargain is...

Continue Reading
Hanmi Compressor Tests Vietnam Before Wider Expansion

Updated Category News Views 0

Compressed air is the sort of factory necessity nobody brags about until it fails, and that is precisely why Hanmi Compressor’s Vietnam plan deserves a sober look. The Daegu-based specialist is not arriving with a grand export victory lap. It is still building the front door: a website, a promotional video, and a process for finding Vietnamese manufacturers and...

Continue Reading
Linux Foundation Unveils the Global Fraud Alliance

Updated Category News Views 99

Who would have thought the tech wizards at the Linux Foundation would step up to tackle fraud on a global scale? That's what we've got with their latest play: the Open Financial Trust Alliance (OFTA). Launched at the Singapore FinTech Festival, they've got their sights on connecting the world's disconnected fraud fight. Think of it as a translator for the tangled mess of...

Continue Reading
Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany

Updated Category News Views 108

A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...

Continue Reading

Top 5 Most Recently Viewed Articles

Rocket Companies Faces Turmoil Amid Zillow's Earnings Shock

Updated Category News Views 212

Rocket Companies Stock Falls After Market Reactions Rocket Companies Inc (NYSE: RKT) is experiencing a downward trend as investors reassess their positions in housing-related stocks. This comes in the wake of a notable sell-off linked to Zillow Group Inc's disappointing earnings report, alongside growing trepidation surrounding artificial intelligence's impact on the real...

Continue Reading
Understanding Dimensional Fund Advisors Ltd.'s Recent Disclosure Actions

Updated Category News Views 139

Introduction to Dimensional Fund Advisors Ltd. Dimensional Fund Advisors Ltd. stands as a prominent investment management firm that focuses on providing high-quality investment solutions. Known for its innovative strategies, the firm has made significant strides in the financial sector. Public Opening Position Disclosure The recent public opening position disclosure by...

Continue Reading
Challenges Ahead for Dunxin Financial Following Delisting

Updated Category News Views 154

Understanding Dunxin Financial's Delisting Process NEW YORK - NYSE American LLC has initiated delisting proceedings for Dunxin Financial Holdings Limited, identified by the ticker symbol DXF for its American depositary shares (ADSs). This move by NYSE Regulation follows a determination that Dunxin Financial's shares do not meet the necessary listing standards, mainly due...

Continue Reading
Pro Music Rights Gains Official Approval as PRO in US Market

Updated Category News Views 198

Pro Music Rights Officially Recognized as a Performing Rights Organization Music Licensing, Inc. (OTC: SONG) has recently celebrated a significant milestone with the official recognition of its wholly-owned subsidiary, Pro Music Rights (PMR), as a Performing Rights Organization (PRO). This acknowledgment, appearing in the Federal Register, elevates PMR’s status in the...

Continue Reading
Dentsply Sirona Welcomes Aldo M. Denti as CCO to Innovate Sales

Updated Category News Views 206

Dentsply Sirona Appoints New Chief Commercial Officer Dentsply Sirona Inc. (NASDAQ: XRAY) has made a significant move to strengthen its commercial strategies by appointing Aldo M. Denti as its new Executive Vice President and Chief Commercial Officer. This change signals a commitment to enhancing customer experience and streamlining operations within the company....

Continue Reading